If you haven’t already heard, Biogen Inc. headquartered in Cambridge, Massachusetts has broken the nearly two decades old barrier to treat Alzheimer’s with their new drug, Aduhelm. Seriously exciting news for our Silver Sagers. Aduhelm attacks the beta-amyloid clumps that form in the brain of Alzheimer’s and dementia patients. Although initial testing trials showed marginal Read more